Views for HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trial.
Total visits
views | |
---|---|
HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trial. | 262 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
Garrett_Nigel_2015.pdf | 309 |
Garrett_Nigel_2015.pdf(legacy) | 21 |
Top country views
views | |
---|---|
United States | 100 |
South Africa | 50 |
Sweden | 22 |
Germany | 15 |
Ireland | 10 |
Netherlands | 9 |
Vietnam | 9 |
India | 6 |
China | 5 |
Finland | 4 |
France | 4 |
Russia | 4 |
Singapore | 3 |
Hungary | 2 |
Brazil | 1 |
Switzerland | 1 |
Israel | 1 |
Iraq | 1 |
Slovakia | 1 |
Top city views
views | |
---|---|
Ashburn | 55 |
Johannesburg | 20 |
Dublin | 10 |
Hanoi | 9 |
Durban | 4 |
Pretoria | 4 |
Bengaluru | 3 |
Des Moines | 3 |
Washington | 3 |
Guntur | 2 |
Santa Clara | 2 |
Beijing | 1 |
Budapest | 1 |
Cape Town | 1 |
Chicago | 1 |
Heidelberg | 1 |
Kunhegyes | 1 |
Lansing | 1 |
Mumbai | 1 |
Nitra | 1 |
Provo | 1 |
Sandton | 1 |
Seattle | 1 |
Singapore | 1 |
Tel Aviv | 1 |
Tzaneen | 1 |
Valencia | 1 |
Villieria | 1 |
Wuxi | 1 |